Regulation of bone remodeling by the central and peripheral nervous system

被引:208
作者
Elefteriou, Florent [1 ]
机构
[1] Vanderbilt Univ, Nashville, TN 37232 USA
关键词
bone; osteoblast; osteoclast; neuron; sympathetic nervous system; hypothalamus; leptin; neuropeptide; adrenergic receptor; neuropeptide Y; endocannabinoid;
D O I
10.1016/j.abb.2008.03.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The homeostatic nature of bone remodeling has become a notion further supported lately by the demonstration that neuropeptides and their receptors regulate osteoblast and osteoclast function in vivo. Following initial studies reporting the presence of nerves and nerve-derived products within the bone microenvironment and the expression of receptors for these neuropeptides in bone cells, new experimental and mechanistic evidence based on in vivo murine genetic and pharmacologic models recently demonstrated that inputs from the central and peripheral nervous system feed into the already complex regulatory machinery controlling bone remodeling. The function of a number of "osteo-neuromediators" has been characterized, including norepinephrine and the beta2-adrenergic receptor, Neuropeptide Y and the Y1 and Y2 receptors, endocannabinoids and the CB1 and CB2 receptors, as well as dopamine, serotonin and their receptors and transporters, Calcitonin gene-related peptide, and neuronal NOS. This new body of evidence suggests that neurons in the central nervous system integrate clues from the internal and external milieux, such as energy homeostasis, glycemia or reproductive signals, with the regulation of bone remodeling. The next major tasks in this new area of bone biology will be to understand, at the molecular level, the mechanisms by which common central neural systems regulate and integrate these major physiological functions, the relative importance of the central and peripheral actions of neuropeptides present in both compartments and their relationship, and how bone cells signal back to central centers, because the definition of a homeostatic function implies the existence of feedback signals. Together, these findings shed a new light on the complexity of the mechanisms regulating bone remodeling and uncovered new potential therapeutic strategies for the design of bone anabolic treatments. This review summarizes the latest advances in this area, focusing on investigations based on in vivo animal studies. Published by Elsevier Inc.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 101 条
[1]   Leptin [J].
Ahima, RS ;
Flier, JS .
ANNUAL REVIEW OF PHYSIOLOGY, 2000, 62 :413-437
[2]   Cart overexpression is the only identifiable cause of high bone mass in melanocortin 4 receptor deficiency [J].
Ahn, Jong Deok ;
Dubern, Beatrice ;
Lubrano-Berthelier, Cecile ;
Lubrano-Berthelier, Cecile ;
Clement, Karine ;
Karsenty, Gerard .
ENDOCRINOLOGY, 2006, 147 (07) :3196-3202
[3]   Effects of CGRP on human osteoclast-like cell formation: a possible connection with the bone loss in neurological disorders? [J].
Akopian, A ;
Demulder, A ;
Ouriaghli, F ;
Corazza, F ;
Fondu, P ;
Bergmann, P .
PEPTIDES, 2000, 21 (04) :559-564
[4]   ALTERNATIVE RNA PROCESSING IN CALCITONIN GENE-EXPRESSION GENERATES MESSENGER-RNAS ENCODING DIFFERENT POLYPEPTIDE PRODUCTS [J].
AMARA, SG ;
JONAS, V ;
ROSENFELD, MG ;
ONG, ES ;
EVANS, RM .
NATURE, 1982, 298 (5871) :240-244
[5]   Effects of β-adrenergic agonists on bone-resorting activity in human osteoclast-like cells [J].
Arai, M ;
Nagasawa, T ;
Koshihara, Y ;
Yamamoto, S ;
Togari, A .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2003, 1640 (2-3) :137-142
[6]   Hypothalamic Y2 receptors regulate bone formation [J].
Baldock, PA ;
Sainsbury, A ;
Couzens, M ;
Enriquez, RF ;
Thomas, GP ;
Gardiner, EM ;
Herzog, H .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (07) :915-921
[7]   Targeted expression of calcitonin gene-related peptide to osteoblasts increases bone density in mice [J].
Ballica, R ;
Valentijn, K ;
Khachatryan, A ;
Guerder, S ;
Kapadia, S ;
Gundberg, C ;
Gilligan, J ;
Flavell, RA ;
Vignery, A .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (07) :1067-1074
[8]   Fluoxetine treatment increases trabecular bone formation in mice (fluoxetine affects bone mass) [J].
Battaglino, R. ;
Vokes, M. ;
Schulze-Spate, U. ;
Sharma, A. ;
Graves, D. ;
Kohler, T. ;
Mueller, R. ;
Yoganathan, S. ;
Stashenko, P. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 100 (06) :1387-1394
[9]   Serotonin regulates osteoclast differentiation through its transporter [J].
Battaglino, R ;
Fu, J ;
Späte, U ;
Ersoy, U ;
Joe, M ;
Sedaghat, L ;
Stashenko, P .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) :1420-1431
[10]   THE OSTEOGENIC STIMULATING EFFECT OF NEUROACTIVE CALCITONIN GENE-RELATED PEPTIDE [J].
BERNARD, GW ;
SHIH, C .
PEPTIDES, 1990, 11 (04) :625-632